Oral wins on convenience and lack of injection risk but has the weakest bioavailability rationale for a peptide of this size
When CJC-1295 is found without DAC, the peptide has a shorter half-life, requiring multiple injections over the day
2015 ORIGINAL Effect of different levels of L-carnitine and lysine-methionine on broiler blood parameters Efecto de suplementacin con L-carnitina y lisina-metionina sobre parmetros de sangre de pollos de engorde Babak Hosseintabar, 1 M.Sc, Mohammad Dadashbeiki, 2 DVM, Mehrdad Bouyeh, 1 Ph.D, Alireza Seidavi, 1 * Ph.D, Ren van den Hoven, 3 Ph.D, Sandra Gamboa, 4,5 , Ph.D
Remarkable Results The findings were impressive: BPC-157 Only Group (12 patients): 11 out of 12 patients (91.6%) experienced significant improvement Only 1 patient (8.3%) saw no improvement BPC-157 + TB4 Combination Group (4 patients): 3 out of 4 patients (75%) showed significant improvement 1 patient (25%) experienced no relief Overall Success Rate : 14 out of 16 patients (87.5%) found relief from their knee pain What Makes BPC-157 Different from Traditional Treatments